A H Jan Danser Selected Research

A H Jan Danser Research Topics

Disease

62	Hypertension (High Blood Pressure) 01/2022 - 06/2003
32	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2011
17	Type 2 Diabetes Mellitus (MODY) 05/2022 - 10/2009
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
16	Proteinuria 01/2022 - 03/2013
15	Heart Failure 01/2021 - 06/2003
14	Neoplasms (Cancer) 01/2022 - 12/2009
13	Albuminuria 01/2022 - 12/2001
12	Chronic Renal Insufficiency 10/2021 - 10/2012
8	Overweight 01/2022 - 01/2016
7	Inflammation (Inflammations) 01/2022 - 02/2013
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2008
7	COVID-19 01/2022 - 01/2020
6	Migraine Disorders (Migraine) 01/2022 - 10/2010
6	Hypertrophy 01/2021 - 02/2002
5	Body Weight (Weight, Body) 01/2022 - 01/2017
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2010
5	Hyperaldosteronism (Conn Syndrome) 01/2021 - 04/2009
5	Infarction (Infarctions) 10/2020 - 11/2002
5	Myocardial Infarction 02/2015 - 11/2002
4	Diabetes Mellitus 01/2021 - 12/2011
4	Atherosclerosis 01/2021 - 01/2019
4	Obesity 01/2020 - 02/2013
4	Pulmonary Hypertension 12/2019 - 10/2015
4	Vascular Remodeling 12/2018 - 01/2013
3	Acidosis 10/2021 - 11/2020
3	Hyperkalemia 01/2021 - 05/2014
3	Infections 10/2020 - 01/2020
3	Ischemia 10/2020 - 04/2006
3	Stroke (Strokes) 01/2019 - 04/2007
3	Cardiomegaly (Heart Hypertrophy) 01/2019 - 10/2010
3	Aneurysm (Aneurysms) 04/2016 - 01/2011
3	Fibrosis (Cirrhosis) 10/2015 - 05/2008
3	Essential Hypertension 02/2013 - 04/2009
3	Cardiotoxicity 01/2012 - 12/2009
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 01/2011

Drug/Important Bio-Agent (IBA)

39	ReninIBA 01/2022 - 02/2002
21	AngiotensinsIBA 01/2022 - 06/2003
21	AldosteroneIBA 01/2022 - 07/2005
15	Angiotensin IIIBA 01/2022 - 12/2001
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2019 - 06/2003
13	Sunitinib (Sutent)FDA Link 01/2022 - 10/2010
13	Endothelin-1 (Endothelin 1)IBA 01/2022 - 10/2010
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2009
12	SaltsIBA 01/2021 - 12/2011
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 03/2013
11	Endothelins (Endothelin)IBA 01/2022 - 01/2012
10	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2011
10	AngiotensinogenIBA 01/2021 - 12/2001
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 11/2002
10	aliskiren FDA Link 08/2017 - 08/2009
8	CreatinineIBA 05/2022 - 11/2011
8	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2022 - 10/2012
8	Prorenin ReceptorIBA 01/2021 - 01/2009
8	EnzymesIBA 10/2020 - 12/2001
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2011
7	AlbuminsIBA 05/2022 - 11/2011
7	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
7	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 07/2005
7	Renin InhibitorsIBA 03/2015 - 08/2007
6	Angiogenesis InhibitorsIBA 01/2022 - 12/2009
5	SodiumIBA 05/2022 - 05/2011
5	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2014
5	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2011
5	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2014
5	Peptides (Polypeptides)IBA 10/2019 - 10/2012
4	dapagliflozinIBA 05/2022 - 05/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2019
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2017
4	Monoclonal AntibodiesIBA 01/2022 - 12/2001
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 05/2019
4	macitentanIBA 03/2020 - 12/2014
4	Glucagon-Like Peptide-1 ReceptorIBA 03/2019 - 01/2016
4	Endothelin Receptors (Endothelin Receptor)IBA 01/2019 - 03/2013
4	Vasodilator Agents (Vasodilators)IBA 10/2018 - 03/2014
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 12/2009
4	Tyrosine Kinase InhibitorsIBA 01/2014 - 12/2009
3	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2019
3	Calcitonin Gene-Related PeptideIBA 01/2022 - 10/2010
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 07/2005
3	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2020 - 11/2016
3	BradykininIBA 10/2020 - 06/2003
3	Angiotensin-Converting Enzyme 2IBA 10/2020 - 01/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 01/2019
3	DiureticsIBA 01/2020 - 02/2013
3	Vasoconstrictor AgentsIBA 12/2019 - 01/2012
3	Perindopril FDA LinkGeneric 03/2016 - 08/2010
3	Angiotensin Receptor AntagonistsIBA 05/2015 - 01/2011
3	Mineralocorticoid Receptor AntagonistsIBA 03/2015 - 04/2009
3	CollagenIBA 05/2014 - 11/2002
3	Eplerenone (Inspra)FDA LinkGeneric 02/2013 - 04/2006
2	Hormones (Hormone)IBA 05/2022 - 04/2009
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022 - 10/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2022
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 10/2020
2	LinagliptinIBA 01/2022 - 11/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 03/2007